V-565

N/A

Report date: 2024/03/08 20:06:23

Base Information

Drug NameV-565
Drug Alias NameV-565
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVhsquared Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVhsquared Ltd
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A